By Divya Grover (Reuters) - Johnson & Johnson (N:JNJ) on Tuesday raised its full-year profit forecast and reported better-than-expected quarterly earnings, helped by strong...
ZURICH (Reuters) - Johnson & Johnson (N:JNJ) said the approval of its proposed acquisition of Swiss biotech firm Actelion (S:ATLN) by the European Commission on Friday meant...
By Pamela Barbaglia LONDON (Reuters) - Some $171.8 billion of cross-border merger and acquisition deals between U.S. and European companies have been announced so far in 2017, the...
Johnson & Johnson (NYSE:JNJ) has received a regulatory approval from the European Commission (EC), thus completing all necessary formalities to close the pending acquisition...
United Therapeutics Corporation (NASDAQ:UTHR) reported adjusted earnings of $3.89 per share (including stock-based compensation benefit) for the first quarter of 2017, which beat...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Engulfing Bearish||15||1||Nov 06, 2017 11:00AM|
|Deliberation Bearish||1D||7||Oct 26, 2017|
|Bullish doji Star||15||13||Nov 06, 2017 07:00AM|
|Bullish Engulfing||1W||15||Jul 23, 2017|
|Three Inside Down||30||15||Nov 03, 2017 12:00PM|
|Bank of America||29.11||29.31||28.67||+0.72||+2.54%||65.83M||15:59:59|
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||$250||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.